AAAAAA

   
Results: 1-13 |
Results: 13
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease
Authors: Stuart, MJ Chao, NS Horning, SJ Wong, RM Negrin, RS Johnston, LJ Shizuru, JA Long, GD Blume, KG Stockerl-Goldstein, KE Goldstein, S
Citation: Mj. Stuart et al., Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease, BIOL BLOOD, 7(10), 2001, pp. 552-560
A decade of progress in allogeneic hematopoietic cell transplantation: 1990-2000
Authors: Stockerl-Goldstein, KE Blume, KG
Citation: Ke. Stockerl-goldstein et Kg. Blume, A decade of progress in allogeneic hematopoietic cell transplantation: 1990-2000, ADV CANC R, 81, 2001, pp. 1-59
Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+cells in patients with advanced hematologic malignancies
Authors: Cao, TM Kusnierz-Glaz, C Valone, F Stockerl-Goldstein, KE Hu, WW Johnston, L Blume, KG Strober, S Negrin, RS
Citation: Tm. Cao et al., Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+cells in patients with advanced hematologic malignancies, CANCER, 91(12), 2001, pp. 2205-2213
Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma
Authors: Liso, A Stockerl-Goldstein, KE Auffermann-Gretzinger, S Benike, CJ Reichardt, V van Beckhoven, A Rajapaksa, R Engleman, EG Blume, KG Levy, R
Citation: A. Liso et al., Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma, BIOL BLOOD, 6(6), 2000, pp. 621-627
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma
Authors: Johnston, LJ Stockerl-Goldstein, KE Hu, WW Negrin, RS Hoppe, RT Blume, KG Horning, SJ
Citation: Lj. Johnston et al., Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma, BIOL BLOOD, 6(5A), 2000, pp. 555-562
High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: Experience in California
Authors: Damon, LE Hu, WW Stockerl-Goldstein, KE Blume, KG Wolf, JL Gold, E Cecchi, GR Irwin, D Glaspy, J Territo, M Miller, W Mason, JR Linker, CA
Citation: Le. Damon et al., High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: Experience in California, BIOL BLOOD, 6(5), 2000, pp. 496-505
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor"mobilization of peripheral blood progenitor cells
Authors: Stockerl-Goldstein, KE Reddy, SA Horning, SJ Blume, KG Chao, NJ Hu, WW Johnston, LJ Long, GD Strober, S Wong, RM Feiner, RH Kohler, S Negrin, RS
Citation: Ke. Stockerl-goldstein et al., Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor"mobilization of peripheral blood progenitor cells, BIOL BLOOD, 6(5), 2000, pp. 506-512
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation
Authors: Cao, TM Negrin, RS Stockerl-Goldstein, KE Johnston, LJ Shizuru, JA Taylor, TL Rizk, NW Wong, RM Blume, KG Hu, WW
Citation: Tm. Cao et al., Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation, BIOL BLOOD, 6(4), 2000, pp. 387-394
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens:Results of a prospective double-blind randomized trial
Authors: Chao, NJ Snyder, DS Jain, M Wong, RM Niland, JC Negrin, RS Long, GD Hu, WW Stockerl-Goldstein, KE Johnston, LJ Amylon, MD Tierney, DK O'Donnell, MR Nademanee, AP Parker, P Stein, A Molina, A Fung, H Kashyap, A Kohler, S Spielberger, R Krishnan, A Rodriguez, R Forman, SJ Blume, KG
Citation: Nj. Chao et al., Equivalence of 2 effective graft-versus-host disease prophylaxis regimens:Results of a prospective double-blind randomized trial, BIOL BLOOD, 6(3), 2000, pp. 254-261
Transplantation of highly purified CD34(+)Thy-I+ hematopoietic stem cells in patients with metastatic breast cancer
Authors: Negrin, RS Atkinson, K Leemhuis, T Hanania, E Juttner, C Tierney, K Hu, WW Johnston, LJ Shizuru, JA Stockerl-Goldstein, KE Blume, KG Weissman, IL Bower, S Baynes, R Dansey, R Karanes, C Peters, W Klein, J
Citation: Rs. Negrin et al., Transplantation of highly purified CD34(+)Thy-I+ hematopoietic stem cells in patients with metastatic breast cancer, BIOL BLOOD, 6(3), 2000, pp. 262-271
Effect of oral glutamine supplementation during bone marrow transplantation
Authors: Dickson, TMC Wong, RM Negrin, RS Shizuru, JA Johnston, LJ Hu, WW Blume, KG Stockerl-Goldstein, KE
Citation: Tmc. Dickson et al., Effect of oral glutamine supplementation during bone marrow transplantation, J PARENT EN, 24(2), 2000, pp. 61-66
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer
Authors: Hu, WW Long, GD Stockerl-Goldstein, KE Johnston, LJ Chao, NJ Negrin, RS Blume, KG
Citation: Ww. Hu et al., A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer, CLIN CANC R, 5(11), 1999, pp. 3411-3418
Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study
Authors: Reichardt, VL Okada, CY Liso, A Benike, CJ Stockerl-Goldstein, KE Engleman, EG Blume, KG Levy, R
Citation: Vl. Reichardt et al., Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study, BLOOD, 93(7), 1999, pp. 2411-2419
Risultati: 1-13 |